Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Maria L. Guerrera"'
Autor:
Jorge J. Castillo, Joshua N. Gustine, Kirsten Meid, Catherine A. Flynn, Maria G. Demos, Maria L. Guerrera, Cristina Jimenez, Amanda Kofides, Xia Liu, Manit Munshi, Nicholas Tsakmaklis, Christopher J. Patterson, Lian Xu, Guang Yang, Zachary R. Hunter, Steven P. Treon
Publikováno v:
HemaSphere, Vol 4, Iss 3, p e363 (2020)
Abstract. Ibrutinib is the first approved therapy for symptomatic patients with Waldenström macroglobulinemia (WM). The approval was based on a single, multicenter, phase II trial in previously treated WM patients. We sought to evaluate whether ther
Externí odkaz:
https://doaj.org/article/141760b83a474b2d84cd37e9f0f50644
Autor:
Ramón Garcia-Sanz, Marzia Varettoni, Cristina Jiménez, Simone Ferrero, Stephanie Poulain, Jesus F. San-Miguel, Maria L. Guerrera, Daniela Drandi, Tina Bagratuni, Mary McMaster, Aldo M. Roccaro, Damien Roos-Weil, Merav Leiba, Yong Li, Luigi Qiu, Jian Hou, C. Fernandez De Larrea, Jorge J. Castillo, M. Dimopoulos, R.G. Owen, S.P. Treon, Z.R. Hunter
Publikováno v:
Seminars in Hematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94915955448647f456a08c2ef474f719
https://doi.org/10.1053/j.seminhematol.2023.03.007
https://doi.org/10.1053/j.seminhematol.2023.03.007
Autor:
Jorge J. Castillo, Shayna R. Sarosiek, Joshua N. Gustine, Catherine A. Flynn, Carly R. Leventoff, Timothy P. White, Kirsten Meid, Maria L. Guerrera, Amanda Kofides, Xia Liu, Manit Munshi, Nicholas Tsakmaklis, Zachary R. Hunter, Christopher J. Patterson, Andrew R. Branagan, Steven P. Treon
Publikováno v:
Blood Advances. 6:1015-1024
Bruton tyrosine kinase (BTK) inhibitors are the only FDA-approved treatments for Waldenström macroglobulinemia (WM). Factors prognostic of survival and predictive of response to BTK inhibitors remained to be clarified. We evaluated 319 patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e6d48ce37fd9ef143b0939f02ea245f
https://doi.org/10.1182/bloodadvances.2021006106
https://doi.org/10.1182/bloodadvances.2021006106